Teva intros authorized Estrace Cream generic

Teva has launched its authorized generic of Allergan’s Estrace Cream (estradiol vaginal cream, 0.01%). The addition to Teva’s women’s health portfolio is indicated to treat moderate-to-severe symptoms of vulvar and vaginal atrophy resulting from menopause.

The drug had U.S. sales of roughly $426 million for the 12 months ended August 2017, according to IQVIA data.